BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9632370)

  • 1. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
    Yu Q; Greig NH; Holloway HW; Brossi A
    J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
    Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
    J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
    J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
    Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
    J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
    Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
    Atack JR; Yu QS; Soncrant TT; Brossi A; Rapoport SI
    J Pharmacol Exp Ther; 1989 Apr; 249(1):194-202. PubMed ID: 2709330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
    Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
    Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
    Siwicka A; Moleda Z; Wojtasiewicz K; Zawadzka A; Maurin JK; Panasiewicz M; Pacuszka T; Czarnocki Z
    J Pineal Res; 2008 Aug; 45(1):40-9. PubMed ID: 18284552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
    Yu QS; Atack JR; Rapoport SI; Brossi A
    FEBS Lett; 1988 Jul; 234(1):127-30. PubMed ID: 3391264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
    Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
    J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
    Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
    Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
    Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
    al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
    Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors.
    Bolognesi ML; Andrisano V; Bartolini M; Minarini A; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 2001 Jan; 44(1):105-9. PubMed ID: 11141093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
    Piazzi L; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
    Bioorg Med Chem; 2007 Jan; 15(1):575-85. PubMed ID: 17008100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.